Author:
NORIS MARINA,AZZOLLINI NADIA,PEZZOTTA ANGELA,MISTER MARILENA,BENIGNI ARIELA,MARCHETTI GIANFRANCO,GAGLIARDINI ELENA,PERICO NORBERTO,REMUZZI GIUSEPPE
Abstract
Abstract. Antigen-dependent and antigen-independent factors have been implicated in the pathophysiology of chronic allograft rejection, but their relative role is not well established. In the Fisher 344→Lewis rat kidney transplant model, we sought (1) to compare the relative efficacy of the novel immunosuppressant, mycophenolate mofetil (MMF), with that of the AT1 receptor blocker, losartan, in preventing the development of chronic graft rejection when given for 52 wk; (2) to examine whether combining MMF with losartan affords better protection than each of the drugs alone. For comparison, the effect of cyclosporine (CsA) to control chronic graft rejection was also assessed. Administration of MMF alone or losartan alone to the kidney allografted rats resulted in a partial decrease in the amount of proteinuria, preservation of glomerular and tubulo-interstitial graft structure, limitation of intragraft cell infiltration, and improvement of graft survival compared with corresponding parameters in untreated, transplanted control rats. Combined treatment with MMF and losartan completely prevented the development of proteinuria, largely reduced glomerular and tubulointerstitial injury, and suppressed intragraft cell infiltration, and all animals survived at the end of the follow-up. Similarly, CsA treatment largely prevented graft injury but failed to achieve 100% animal survival. We have shown that MMF synergizes with the angiotensin II receptor antagonist, losartan, in simultaneously targeting complementary pathways of chronic allograft rejection. Combining MMF and angiotensin II receptor blocker offers superior long-term renoprotection as compared with CsA. Together, these findings provide the basis to prevent chronic injury and progressive dysfunction after renal transplantation.
Publisher
American Society of Nephrology (ASN)
Subject
Nephrology,General Medicine
Reference40 articles.
1. Chronic transplant rejection: Magnitude of the problem and pathogenetic mechanisms
2. Terasaki PI, Cecka JM, Cho Y, Ciccciarelli J, Cohn M, Gjerston D, Lim E, Mickey MR, Ogura K, Park MS, Takemoto S, Yuge J: Overview. In: Clinical Transplants, edited by Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, 1990, pp 585 -601
3. Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
4. CHRONIC REJECTION—AN UNDEFINED CONUNDRUM
5. BOTH ALLOANTIGEN-DEPENDENT AND -INDEPENDENT FACTORS INFLUENCE CHRONIC ALLOGRAFT REJECTION
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献